MBI Graduate Success Story: T. Breeders

One of MBI’s most notable startup success stories is T. Breeders, a biotech company whose journey exemplifies the impact of MBI’s early-stage support. Founded by Morey Kraus as a small startup in our vibrant community, T. Breeders focused on groundbreaking research in cell therapy, specifically harnessing T-cells to develop novel treatments. MBI’s role in providing laboratory space, mentorship, and a collaborative environment helped the company establish a strong foundation, attract talent, and secure valuable industry connections.

At MBI, T. Breeders benefited from the organization’s resources and network, allowing the company to refine its technologies and move from concept to impactful research. Through MBI’s support, T. Breeders developed critical advances in cell-based therapy, positioning itself as a promising player in the emerging field of regenerative medicine. The startup’s success quickly drew attention within the biotech industry, culminating in its acquisition by ViaCell, a prominent company focused on cellular therapies.

ViaCell’s acquisition of T. Breeders underscored the startup’s significant achievements and potential for further innovation. The acquisition allowed T. Breeders’ pioneering research to reach new heights, providing ViaCell with advanced technology in cell therapy and reinforcing the importance of supporting early-stage biotech companies. Today, T. Breeders’ journey from an MBI-supported startup to a high-profile acquisition highlights the long-lasting impact of MBI’s mission to foster innovation and drive economic growth in Central Massachusetts.

For MBI, T. Breeders’ success story serves as both a milestone and a motivation to continue supporting pioneering companies on their path to transforming healthcare. This story is a reminder of the importance of nurturing startups that dare to tackle complex challenges, laying the groundwork for future breakthroughs in life sciences.